Axicabtagene Ciloleucel Outperforms Conventional First-Line Therapy
In a groundbreaking comparative study published in BMC Cancer, researchers have provided compelling evidence demonstrating the superiority of axicabtagene ciloleucel ...
In a groundbreaking comparative study published in BMC Cancer, researchers have provided compelling evidence demonstrating the superiority of axicabtagene ciloleucel ...
In a groundbreaking discovery that could reshape the landscape of lymphoma treatment, Australian scientists have unveiled a critical cellular mechanism ...
Relapsed and refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) present some of the most formidable challenges within ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine